Mychonastes sp. 246 Suppresses Human Pancreatic Cancer Cell Growth via IGFBP3- PI3K-mTOR Signaling

키워드

참고문헌 (67)

1. Hu JX, "Pancreatic cancer: a review of epidemiology, trend, and risk factors", World J. Gastroenterol, 27, pp.4298~4321 (2021)
2. Quante AS, "Projections of cancer incidence and cancer-related deaths in Germany by 2020 and 2030", Cancer Med, 5, pp.2649~2656 (2016)
3. Principe DR, "The current treatment paradigm for pancreatic ductal adenocarcinoma and barriers to therapeutic efficacy", Front. Oncol, 11, pp.688377~ (2021)
4. Lee Soon, "Gossypol Induces Apoptosis of Human Pancreatic Cancer Cells via CHOP", Endoplasmic Reticulum Stress Signaling Pathway, 2022, pp.32(5), 645~656[DOI]
5. Springfeld C, "Chemotherapy for pancreatic cancer", Presse Med, 48, pp.e159~e174 (2019)
6. Dyshlovoy SA, "Marine compounds and cancer: where do we stand?", Mar. Drugs, 13, pp.5657~5665 (2015)
7. Atanasov AG, "International natural product sciences, T.; supuran, C.T. natural products in drug discovery: advances and opportunities", Nat. Rev. Drug Discov, 20, pp.200~216 (2021)
8. Borowitzka MA, "Microalgae as sources of pharmaceuticals and other biologically active compounds", J. Appl. Phycol, 7, pp.3~15 (1995)
9. Becker EW, "Micro-algae as a source of protein", Biotechnol. Adv, 25, pp.207~210 (2007)
10. Lauritano C, "Bioactivity screening of microalgae for antioxidant, anti-inflammatory, anticancer, anti-diabetes, and antibacterial activities", Front. Mar. Sci, 3, pp.68~ (2016)
11. 장현진, "토착 담수미세조류 메탄올 추출물의 항산화 및 항암효과", KSBB Journal, 36(2), pp.154~164 (2021), 한국생물공학회[DOI]
12. Witsch E, "Roles for growth factors in cancer progression", Physiology (Bethesda), 25, pp.85~101 (2010)
13. Elghazi L, "Role of nutrients and mTOR signaling in the regulation of pancreatic progenitors development", Mol. Metab, 6, pp.560~573 (2017)
14. Waters AM, "KRAS: the critical driver and therapeutic target for pancreatic cancer", Cold Spring Harb. Perspect. Med, 8, pp.a031435~ (2018)
15. Iriana S, "Targeting mTOR in pancreatic ductal adenocarcinoma", Front. Oncol, 6, pp.99~ (2016)
16. Schneeweis C, "Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition", Cancer Commun. (Lond), 42, pp.360~364 (2022)
17. Mortazavi M, "Prospects of targeting PI3K", AKT, Crit. Rev. Oncol. Hematol, pp.2022, 176[DOI]
18. Porta C, "Targeting PI3K", Akt, Front. Oncol, pp.2014, 4[DOI]
19. Fingar DC, "mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1", eukaryotic translation initiation factor 4E, 2004, pp.24, 200~216
20. Roncolato F, "PI3K", AKT, Cochrane Database Syst. Rev, pp.2019, 10[DOI]
21. Lemmon MA, "Cell signaling by receptor tyrosine kinases", Cell, 141, pp.1117~1134 (2010)
22. Zhao L, "Class I PI3K in oncogenic cellular transformation", Oncogene, 27, pp.5486~5496 (2008)
23. Trapnell C, "TopHat: discovering splice junctions with RNA-Seq", Bioinformatics, 25, pp.1105~1111 (2009)
24. Roberts A, "Improving RNA-Seq expression estimates by correcting for fragment bias", Genome Biol, 12, pp.R22~ (2011)
25. Kielkopf CL, "Bradford assay for determining protein concentration", Cold Spring Harb. Protoc, 2020, pp.102269~ (2020)
26. López-García J, "HaCaT keratinocytes response on antimicrobial atelocollagen substrates:extent of cytotoxicity, cell viability and proliferation", J. Funct. Biomater, 5, pp.43~57 (2004)
27. Ayres Pereira M, "Metastasis in pancreatic ductal adenocarcinoma: current standing and methodologies", Genes (Basel), 11, pp.6~ (2019)
28. Qin C, "Metabolism of pancreatic cancer: paving the way to better anticancer strategies", Mol. Cancer, 19, pp.50~ (2020)
29. Zhang L, "Challenges in diagnosis of pancreatic cancer", World J. Gastroenterol, 24, pp.2047~2060 (2018)
30. Lee J, "Gene expression profiles associated with radio-responsiveness in locally advanced rectal cancer", Biology (Basel), 10, pp.500~ (2021)
31. Faubert B, "Metabolic reprogramming and cancer progression", Science, 368(6487), pp.eaaw5473~ (2020)
32. Tarrado-Castellarnau M, "Oncogenic regulation of tumor metabolic reprogramming", Oncotarget, 7, pp.62726~62753 (2016)
33. Mayers JR, "Nature and nurture: what determines tumor metabolic phenotypes?", Cancer Res, 77, pp.3131~3134 (2017)
34. Minhas AK, "A review on the assessment of stress conditions for simultaneous production of microalgal lipids and carotenoids", Front. Microbiol, 7, pp.546~ (2016)
35. Yuan C, "Mychonastes afer HSO-3-1 as a potential new source of biodiesel", Biotechnol. Biofuels, 4, pp.47~ (2011)
36. 차선희, "해양 미세조류 Nannochloropsis oculata 추출ㆍ분획물의 ACE, α-glucosidase 및 암세포 저해 활성", 한국수산과학회지, 43(5), pp.437~444 (2010), 한국수산과학회
37. Shahzad N, "Phytosterols as a natural anticancer agent: current status and future perspective", Biomed. Pharmacother, 88, pp.786~794 (2017)
38. Xu H, "Anti-breast-cancer activity exerted by beta-sitosterol-d-glucoside from sweet potato via upregulation of MicroRNA-10a and via the PI3K-Akt signaling pathway", J. Agric. Food Chem, 66, pp.9704~9718 (2018)
39. Sarkar S, "A novel compound β-sitosterol-3-O-β-D-glucoside isolated from Azadirachta indica effectively induces apoptosis in leukemic cells by targeting G0", G1 populations, 2020, pp.57, 27~32
40. Andrea Fratter, "New Chitosan Salt in Gastro-Resistant Oral Formulation Could Interfere with Enteric Bile Salts Emulsification of Diet Fats: Preliminary Laboratory Observations and Physiologic Rationale", Journal of Medicinal Food, 17(6), pp.723~729 (2014), 한국식품영양과학회
41. Abd El-Hack ME, "Microalgae in modern cancer therapy:current knowledge", Biomed. Pharmacother, 111, pp.42~50 (2019)
42. Saadaoui I, "Algae-derived bioactive compounds with antilung cancer potential", Mar. Drugs, 18, pp.197~ (2020)
43. Chu TLH, "Cell cycle-dependent tumor engraftment and migration are enabled by aurora-A", Mol. Cancer Res, 16, pp.16~31 (2018)
44. Fan Z, "Role of the PI3K", AKT pathway in modulating cytoskeleton rearrangements and phenotype switching in rat pulmonary arterial vascular smooth muscle cells, 2014, pp.33, 12~19
45. Deng S, "PI3K", AKT signaling tips the balance of cytoskeletal forces for cancer progression, 2022, pp.14, 1652~
46. Thomas D, "Role of tumor and stroma-derived IGF", IGFBPs in pancreatic cancer, 2020, pp.12, 1228~
47. Jin L, "Insulin growth factor binding protein 7 (IGFBP7)-related cancer and IGFBP3 and IGFBP7crosstalk", Front. Oncol, 10, pp.727~ (2020)
48. Kerr A, "Noncoding RNA actions through IGFs and IGF binding proteins in cancer", Oncogene, 41, pp.3385~3393 (2020)
49. Vadlakonda L, "The paradox of Akt-mTOR interactions", Front. Oncol, 3, pp.165~ (2013)
50. Li W, "Targeting AMPK for cancer prevention and treatment", Oncotarget, 6, pp.7365~7378 (2015)
51. Inoki K, "TSC2 mediates cellular energy response to control cell growth and survival", Cell, 115, pp.577~590 (2003)
52. Sook SH, "Reactive oxygen species-mediated activation of AMP-activated protein kinase and c-Jun N-terminal kinase plays a critical role in beta-sitosterol-induced apoptosis in multiple myeloma U266 cells", Phytother. Res, 28, pp.387~394 (2014)
53. Arul Albert Baskar, "b-Sitosterol Prevents Lipid Peroxidation and Improves Antioxidant Status and Histoarchitecture in Rats with 1,2-Dimethylhydrazine-Induced Colon Cancer", Journal of Medicinal Food, 15(4), pp.335~343 (2012), 한국식품영양과학회[DOI]
54. Cuyas E, "Cell cycle regulation by the nutrient-sensing mammalian target of rapamycin (mTOR) pathway", Methods Mol. Biol, 1170, pp.113~144 (2014)
55. Pena-Leon V, "mTOR Pathway is involved in energy homeostasis regulation as a part of the gut-brain axis", Int. J. Mol. Sci, 21, pp.5715~ (2020)
56. Rojo F, "4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis", Clin. Cancer Res, 13, pp.81~89 (2007)
57. Khan MI, "The promising future of microalgae: current status, challenges, and optimization of a sustainable and renewable industry for biofuels, feed, and other products", Microb. Cell Fact, 17, pp.36~ (2018)
58. Wan X, "Effect of marine microalga Chlorella pyrenoidosa ethanol extract on lipid metabolism and gut microbiota composition in high-fat diet-fed rats", Mar. Drugs, 16, pp.498~ (2018)
59. Arab S, "Chemopreventive effect of spirulina microalgae on an animal model of glioblastoma via down-regulation of PI3K", AKT, miR-125B expression, pp.Phytother. Res, 2021[DOI]
60. Silva M, "Bioactive compounds of Arthrospira spp. (Spirulina) with potential anticancer activities: a systematic review", ACS Chem. Biol, 16, pp.2057~2067 (2021)
61. Liao G, "Phycocyanin Inhibits tumorigenic potential of pancreatic cancer cells: role of apoptosis and autophagy", Sci. Rep, 6, pp.34564~ (2016)
62. Langhans SA, "Three-dimensional in vitro cell culture models in drug discovery and drug repositioning", Front. Pharmacol, 9, pp.6~ (2018)
63. Jensen C, "Is it time to start transitioning from 2D to 3D cell culture?", Front. Mol. Biosci, 7, pp.33~ (2020)
64. Schmidt M, "Spheroid-based 3-dimensional culture models: gene expression and functionality in head and neck cancer", Oncol. Rep, 35, pp.2431~2440 (2016)
65. Na TY, "The functional activity of E-cadherin controls tumor cell metastasis at multiple steps", Proc. Natl. Acad. Sci. USA, 117, pp.5931~5937 (2020)
66. Cheok CF, "Protecting normal cells from the cytotoxicity of chemotherapy", Cell Cycle, 11, pp.2227~2228 (2012)
67. Schirrmacher V, "From chemotherapy to biological therapy: a review of novel concepts to reduce the side effects of systemic cancer treatment (Review)", Int. J. Oncol, 54, pp.407~419 (2019)

관련 논문AI추천